OrbiMed Capital GP VII LLC

CIK 1760648 · last filed 2025-12-18

OrbiMed Capital GP VII LLC is a corporate insider who has filed 31 SEC Form 4 insider transactions across 11 companies since 2020. The most recent filing shows the insider disposed of $11.4M of KROS on Dec 18, 2025. Across all open-market trades the lifetime net is +$225.9M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $226.5M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$226.48M

Companies

11

Total Filings

31

Lifetime Open-Market Net

$225.95M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
KROS Director 45,057 $10.15 $457.3K $18.01M 2 2025-12-18
PASG 10%+ Owner 6,279,600 $5.81 $36.48M $17.76M 13 2025-06-26
MBX Director 3,205,930 $35.51 $113.84M $6.06M 1 2025-02-19
Theseus Pharmaceuticals, Inc. (THRX) Delisted Director 0 $4.06 $0 $7.74M 3 2024-02-14
Damora Therapeutics, Inc. (GLTO) Delisted Director 914,267 $28.69 $26.23M $52.66M 2 2023-07-17
Kinnate Biopharma Inc. (KNTE) Delisted Director 794,368 $2.65 $2.11M $70.72M 2 2023-05-02
Terns Pharmaceuticals, Inc. (TERN) Delisted Director 762,400 $52.95 $40.37M $5.00M 1 2022-12-28
Sierra Oncology, Inc. (SRRA) Delisted Director 226,704 $54.99 $12.47M $0 1 2022-01-28
JANX Director 2,403,566 $13.56 $32.59M -$22.50M 1 2021-12-17
Repare Therapeutics Inc. (RPTX) Delisted Director 97,293 $2.65 $257.8K $40.50M 3 2021-09-02
IMRA Director 2,532,402 $17.02 $43.10M $30.00M 1 2021-07-16

Recent Filings

31 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2025-12-18 KROS Disp (D) −643,566 -$11.42M EDGAR
2025-06-26 PASG Sell (S) −1,167,314 -$394.5K EDGAR
2025-04-24 PASG Sell (S) −471,144 -$157.5K EDGAR
2025-04-17 PASG Sell (S) −298,108 -$99.4K EDGAR
2025-02-19 MBX Buy (P) +572,016 $6.06M EDGAR
2025-01-14 PASG Sell (S) −446,438 -$284.4K EDGAR
2025-01-08 PASG Sell (S) −294,048 -$206.6K EDGAR
2024-12-26 PASG Sell (S) −460,642 -$276.4K EDGAR
2024-12-11 PASG Sell (S) −124,552 -$104.0K EDGAR
2024-11-05 Mixed +10,709,024 $40.00M
Showing 110 of 31
Page 1 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.